What is Entheogenic Practice?
Entheogenic practice refers to the deliberate, ritually contextualized use of psychoactive substances—typically plants or fungi—to induce altered states of consciousness for spiritual, religious, or transformative purposes. Distinct from recreational drug use, entheogenic practice involves set (mindset), setting (ceremonial or therapeutic environment), and intention aligned with personal growth, healing, mystical experience, or communion with the sacred. Common entheogens include psilocybin mushrooms, ayahuasca, peyote, San Pedro cactus, iboga, and certain synthetic compounds like LSD when used in ceremonial contexts.
The term “entheogen” was introduced to scholarly discourse to honor indigenous traditions and distinguish sacramental use from the stigmatized language of “drugs” or “hallucinogens.” Entheogenic practice may occur within structured religious ceremonies (such as Native American Church peyote rituals or Santo Daime ayahuasca services), therapeutic frameworks (psychedelic-assisted psychotherapy), or personal explorations guided by experienced facilitators.
Origins & Lineage
Entheogenic use predates written history. Archaeological evidence suggests ritual use of psychoactive plants stretches back millennia across continents. Psilocybin mushroom iconography appears in Mesoamerican art dating to 1500 BCE. The Eleusinian Mysteries of ancient Greece (circa 1500 BCE to 392 CE) likely involved a psychoactive kykeon brew. Indigenous Amazonian ayahuasca traditions and Andean San Pedro ceremonies have continuous lineages spanning centuries.
In North America, the Native American Church has employed peyote in religious ceremony since the late 19th century, with legal protections established through decades of advocacy. The Bwiti tradition of Gabon has used iboga root bark in initiation rites for generations.
Modern Western engagement began in earnest in the mid-20th century. R. Gordon Wasson’s 1957 Life magazine article on Mexican psilocybin mushroom ceremonies introduced millions to entheogenic practice. The 1960s saw widespread experimentation, clinical research by figures like Stanislav Grof and Ram Dass (Richard Alpert), and subsequent backlash culminating in prohibition. The term “entheogen” itself emerged from a 1979 correspondence among ethnobotanists Carl A.P. Ruck, Jeremy Bigwood, Danny Staples, Jonathan Ott, and R. Gordon Wasson, seeking language that honored sacred use.
How It’s Practiced
Entheogenic practice varies widely by tradition, substance, and intention. Indigenous ceremonies often involve days of preparation: dietary restrictions (dieta), seclusion, prayer, and consultation with elders or shamans. The ceremony itself may include ritual purification, song (icaros in ayahuasca traditions), drumming, silence, and collective intention-setting. Participants typically ingest the entheogen under supervision, then navigate the experience supported by guides who hold space, offer reassurance, and may intervene with traditional healing techniques.
Contemporary Western contexts range from underground facilitator-led circles to legal clinical trials to destination retreats in jurisdictions where certain entheogens remain legal. Sessions often begin with intention-setting, include musical support (live or recorded), emphasize physical safety and psychological container, and conclude with integration—processing insights through journaling, therapy, or community discussion.
Solo entheogenic practice exists but is generally discouraged by experienced practitioners due to safety and psychological risks without support.
Entheogenic Practice Today
The 21st century has seen a resurgence of interest, often termed the “psychedelic renaissance.” Clinical research at institutions like Johns Hopkins, Imperial College London, and MAPS has produced FDA Breakthrough Therapy designations for psilocybin and MDMA in treating depression, PTSD, and addiction. Decriminalization and legalization movements have gained ground in U.S. cities and states, as well as in countries like Canada (psilocybin therapy exemptions) and the Netherlands (legal psilocybin truffles).
Seekers encounter entheogenic practice through multiple channels: legal ayahuasca churches (União do Vegetal, Santo Daime) operating under religious freedom protections; underground facilitator networks; retreat centers in Peru, Costa Rica, Jamaica, and the Netherlands; clinical trials; and guided ketamine therapy now available in many jurisdictions.
Integration circles, harm reduction organizations like the Zendo Project, and psychedelic education nonprofits provide community support. Academic conferences (Breaking Convention, Horizons) and publications (the Journal of Psychedelic Studies) have formalized discourse.
Common Misconceptions
Entheogenic practice is not inherently therapeutic. While many report profound benefit, others experience retraumatization, psychological distress, or no lasting change. Set, setting, preparation, and integration matter as much as the substance itself.
It is not universally legal. Despite changing attitudes, most classical entheogens remain Schedule I substances in the United States and prohibited in many countries, with narrow exceptions for religious or research use.
Entheogenic practice is not a shortcut to enlightenment or a replacement for sustained contemplative discipline. Many traditions view entheogens as tools or catalysts, not destinations.
It is not without risk. Contraindications include certain psychiatric conditions, cardiovascular issues, and medication interactions. Psychological challenges during experiences can be severe, and integration failures can lead to dissociation or spiritual bypassing.
How to Begin
Those drawn to entheogenic practice should begin with education and honest self-assessment. Michael Pollan’s How to Change Your Mind (2018) offers accessible history and science. James Fadiman’s The Psychedelic Explorer’s Guide provides practical frameworks. Gabor Maté and others have written on therapeutic applications.
Seek qualified guides with verifiable training, references, and adherence to harm reduction principles. Organizations like the Multidisciplinary Association for Psychedelic Studies (MAPS), Chacruna Institute, and the Council on Spiritual Practices provide vetted resources and directories.
Consider participating in integration circles or psychedelic peer-support groups before undertaking an entheogenic experience. Screen facilitators carefully—ask about training lineage, safety protocols, medical screening procedures, and their relationship to the traditions they draw from.
For those in jurisdictions with legal access, ketamine-assisted therapy or clinical trials may offer supervised entry points. Always prioritize physical and psychological safety, informed consent, and cultural respect when engaging with practices rooted in indigenous traditions.